Medicine and Dentistry
Prospective Cohort Study
100%
Anthracycline
100%
Cardiotoxicity
100%
Doxorubicin
50%
Diastolic Dysfunction
33%
Liposomal Daunorubicin
33%
Analysis of Variance
16%
Outcome Assessment
16%
Tertiary Care
16%
Combination Therapy
16%
Acute Lymphoblastic Leukemia
16%
Childhood Cancer
16%
Systolic Function
16%
Systolic Dysfunction
16%
Toddlers
16%
Diastolic Function
16%
Nursing and Health Professions
Prospective Cohort Study
100%
Anthracycline
100%
Cardiotoxicity
100%
Doxil
50%
Diastolic Dysfunction
33%
Daunorubicin
33%
Tertiary Care Center
16%
Toddlers
16%
Combination Therapy
16%
Analysis of Variance
16%
Outcome Assessment
16%
Systolic Dysfunction
16%
Childhood Cancer
16%
Acute Lymphoblastic Leukemia
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiotoxicity
100%
Prospective Cohort Study
100%
Anthracycline
100%
Doxorubicin
50%
Daunorubicin
33%
Diastolic Dysfunction
33%
Chemotherapy
16%
Systolic Dysfunction
16%
Combination Therapy
16%
Acute Lymphoblastic Leukemia
16%
Childhood Cancer
16%
Food Science
Analysis of Variance
100%